3D echoendoscopy and miniprobes for rectal cancer staging by Castro-Poças, F. et al.
Castro-Poças F, Dinis-Ribeiro M, Rocha A, Araújo T, Pedroto I. 3D echoen-
doscopy and miniprobes for rectal cancer staging. Rev Esp Enferm Dig 2018; 
110(5):306-310.
DOI: 10.17235/reed.2018.4453/2016
3D echoendoscopy and miniprobes for rectal cancer staging
ORIGINAL PAPERS
Fernando Castro-Poças1,2,5, Mário Dinis-Ribeiro3, Anabela Rocha2,4, Tarcísio Araújo5 and Isabel Pedroto2,5
Departments of 1Ultrasound and 5Gastroenterology. Santo António Hospital. Porto Hospital Center. Porto, Portugal. 2Institute of Ciências Biomédicas 
Abel Salazar. University of Porto. Porto, Portugal. 3Center for Health Technology and Services Research. Faculty of Medicine. University of Porto. 
Porto, Portugal. 4Unit of Digestive Surgery. Service of General Surgery. Santo António Hospital. Porto Hospital Center. Porto, Portugal
Received: 27/05/2016 · Accepted: 02/12/2017
Correspondence: Fernando Castro-Poças. Departments of Ultrasound and Gastroenterology. Santo António 
Hospital. Porto Hospital Center. Largo do Prof. Abel Salazar. 4099-001 Porto, Portugal. e-mail: castro.pocas@sapo.pt
ABSTRACT
Background: rectal cancer staging using rigid probes or 
echoendoscopes has some limitations. The aim of the study 
was to compare rectal cancer preoperative staging using 
conventional endoluminal ultrasonography with three-di-
mensional endoscopic ultrasonography and miniprobes. 
Materials and methods: sixty patients were included and 
evaluated with: a) a conventional echoendoscope (7.5 and 
12 MHz); b) miniprobes (12 MHz); and c) the Easy 3D Frees-
can software for three-dimensional endoscopic ultrasonog-
raphy. The reference or gold standard was conventional 
endoluminal ultrasonography in all cases and pathologi-
cal assessment for those without preoperative therapy. The 
differences in T and N staging accuracy in both longitudinal 
and circumferential extension were evaluated. 
Results: with regard to T staging, conventional endolumi-
nal ultrasonography had an accuracy of 85% (compared 
to pathological analysis), and the agreement between 
miniprobes vs conventional endoluminal ultrasonography 
(kappa = 0.81) and three-dimensional endoscopic ultraso-
nography vs conventional endoluminal ultrasonography 
(k = 0.87) was significant. In addition, miniprobes had an 
accuracy of 82% and three-dimensional endoscopic ultra-
sonography had a higher accuracy (96%). With regard to 
N staging, conventional endoluminal ultrasonography had 
an accuracy of 91% with a sensitivity of 78%. However, the 
agreement between miniprobes and conventional endolu-
minal ultrasonography and three-dimensional endoscopic 
ultrasonography and conventional endoluminal ultraso-
nography (k = 0.70) was lower. Interestingly, miniprobes 
had a lower accuracy of 81% whereas three-dimensional 
endoscopic ultrasonography had an accuracy of 100% with-
out any false negative. No false positives were observed 
in any of the techniques. Accuracy for T and N staging was 
not influenced by longitudinal or circumferential extensions 
of the tumor in all types of endoscopic ultrasonography 
analyzed. 
Conclusions: miniprobes and especially three-dimensional 
endoscopic ultrasonography may be relevant during rectal 
cancer staging.
Key words: Human colon. Miniprobes. Endoscopic Ultraso-
nography. Intestinal wall.
INTRODUCTION
Magnetic resonance imaging, endoluminal ultrasound 
and computed tomography are imaging tools commonly 
used to evaluate rectal tumor staging (1). Rectal endolu-
minal ultrasonography (US) with rigid probes or endo-
scopic ultrasonography (EUS) is the preferential method 
for local staging of rectal carcinoma (RC) and decisively 
influences the therapeutic approach of patients (2). Nev-
ertheless, its accuracy varies significantly, ranging from 
63% to 95% for T staging and from 64% to 80% for N 
staging (1,3-5). It is well known that operator expertise 
is an important factor in the accuracy of RC by endolu-
minal US (6). However, tumor anatomical characteristics 
(e.g., stenosis), lymph node location (e.g., pelvic lateral 
nodes) or criteria (e.g., size) may also influence the final 
result (4,7).
Conventional EUS (C-EUS) does not provide whole tumor 
assessment for all stenosing tumors. Miniprobe EUS 
(mp-EUS) may easily overcome these obstacles due to 
its reduced diameter and flexibility (8,9). mp-EUS may be 
the most adequate ultrasonographic tool for the differen-
tial diagnosis of tumors limited to the mucosa (T1m) or 
with involvement of the submucosa (T1sm) as it uses high 
frequencies and thus resolves the limitations of C-EUS 
(10,11). 
C-EUS provides only two-dimensional images of the lesions 
and structures. Three- dimensional EUS (3D-EUS) may be 
able to provide simultaneous spatial information of differ-
ent planes and even a multi-plane vision. It also allows the 
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isolation of structures or lesions of interest and presents 
them in different perspectives, changing their texture and/
or transparency (12-15). However, the application of 3D-EUS 
in this setting has rarely been reported (12,14,16,17). There-
fore, we aimed to compare RC preoperative staging using 
C-EUS with 3D-EUS and mp-EUS.
METHODS
Selection of participants
The prospective study was approved by the Ethics Com-
mittee for Health of our hospital. Patients with RC (defined 
as located up to 15 cm from the anal verge) that under-
went endoscopic ultrasonography staging of the disease 
gave their written informed consent prior to inclusion in the 
study. Patients less than 18 years of age, pregnant wom-
en or individuals unable to give informed consent were 
excluded.
Procedures 
Two enemas were given one hour before the procedures. 
Three types of equipment were used in staging: a) a con-
ventional echoendoscope with frequencies of 7.5 and 12 
MHz (Olympus GF-UM20®); b) mp-EUS with 12 MHz (Olym-
pus UM-2R®); and c) 3D-EUS with the Easy 3D Freescan 
software from Echotech®. The assessment for T and N stag-
es (defined in accordance with TNM staging [18]) was ini-
tiated with mp-EUS followed by C-EUS. 3D-EUS was the 
final technique performed and images were acquired via a 
conventional echoendoscope. The identification of lymph 
nodes in the perirectal space was conducted from the distal 
rectum to the iliac vessels. The differences in the ability of 
the three techniques to assess the entire lesion were also 
assessed.
Reference tests
Patients were divided in two groups according to the use 
of neoadjuvant therapy with radio/chemotherapy. Prior 
assessment with a conventional echoendoscopy was per-
formed before neoadjuvant therapy and was considered 
as a reference in all cases. Pathological assessment after 
surgery was considered as the gold standard for those who 
did not receive preoperative therapy. 
Statistical analysis
The PASW® version 21 software was used for the analysis. 
The kappa coefficient was used to estimate the agreement 
between techniques and accuracy; this was calculated as 
the proportion of true results versus the total number of 
patients. In addition, sensitivity and specificity were esti-
mated as the proportion of true positive or negative cases, 
respectively. 
The relationship between longitudinal or circumferential 
extent of the tumor and staging accuracy was evaluated for 
all three techniques using a Spearman’s correlation.
RESULTS
Sixty patients aged between 34 and 89 years (mean value 
of 63.8 ± 11.8) were assessed, and 36 (60%) patients were 
male. All patients underwent surgery, 27 (45%) without pre-
operative adjuvant therapy.
Mp-EUS assessed the lesion in its entirety in 97% of cases, 
whereas this was achieved less frequently via C-EUS and 
3D-EUS, in 85% of cases (p = 0.01). Staging was not possible 
using C-EUS in 15% (n = 9) of cases vs 3% (n = 2) of cases with 
mp-EUS, due to tumor stenosis. In these cases where it was 
not possible to evaluate the whole of the tumor, T and N stag-
es results were based on the tumor extent that was observed.
T staging 
Comparison of T staging by mp-EUS, 3D-EUS and C-EUS 
in all patients (n = 60) (Table 1)
Both the mp-EUS and 3D-EUS techniques were highly con-
cordant with C-EUS for T staging, with Kappa coefficients of 
0.81 and 0.87. Global accuracy of T staging by mp-EUS com-
pared to C-EUS was 86.7% and 81.7% compared to 3D-EUS.
Comparison of T staging obtained using different EUS 
techniques and anatomopathological staging (APS)  
(n = 27) (Table 2)
T staging by C-EUS, mp-EUS and 3D-EUS was concordant 
with APS with Kappa coefficient values of 0.81, 0.76 and 
0.95, respectively. 
Simultaneous comparison of T staging using the three 
EUS techniques and T APS (n = 27) (Table 2)
There were no significant differences with regard to the 
simultaneous comparison of the three techniques (p = 0.75).
N staging
Comparison of N staging by mp-EUS, 3D-EUS and C-EUS 
staging in all patients (n = 60) (Table 3) 
The mp-EUS and 3D-EUS analyses were concordant with 
C-EUS for N staging, with kappa coefficients of 0.65 and 
0.79, respectively.
The sensitivity of C-EUS compared to mp-EUS and 3D-EUS 
for the identification of metastasized nodes was 73.1% and 
92.3%, respectively. The corresponding values for specificity 
were 91.2% and 79.4%, positive predictive values were 86.4% 
and 77.4%, negative predictive values were 81.6% and 93.1% 
and global accuracy was 83.3% and 85%, respectively. 
Comparison of N staging obtained via different EUS 
techniques and APS (n = 21) (Table 4) 
Anatomopathological information with regard to the pres-
ence of metastasized nodes was available in 21 (77.8%) cas-
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Table 1. Accuracy and agreement for T staging using conventional (C-EUS) as a reference for miniprobes  
(accuracy = 87%, kappa = 0.81) and 3D-EUS (accuracy = 82%, kappa = 0.87). Total n = 60
Accuracy (%)
C-EUS (n)
T staging
T1m T1sm T2 T3 T4
Miniprobes (n) 87 (74-100)
 T1m 100 (100-100) 8
 T1sm 80 (65-95) 4 1
 T2 73 (56-90) 2 8 1
 T3 96 (89-100) 1 26
 T4 67 (49-85) 3 6
3D-EUS (n) 82 (68-97)
 T1m 100 (100-100) 5 2
 T1sm 60 (42-78) 3
 T2 73 (56-90) 8
 T3 89 (77-100) 3 24
 T4 100 (100-100) 3 9
Table 2. Accuracy and agreement for T staging using pathology as a reference for conventional EUS (C-EUS) (accuracy = 
85%, kappa = 0.81), miniprobes (accuracy = 82%, kappa = 0.76) and 3D-EUS (accuracy = 96%, kappa = 0.95). Total n = 27
Accuracy (%)
Pathology
T staging
T1m T1sm T2 T3 T4
C-EUS (n) 85 (72-98)
 T1m 80 (65-95) 8
 T1sm 75 (59-91) 2 3
 T2 100 (100-100) 1 4
 T3 100 (100-100) 5 1
 T4 75 (59-91) 3
Miniprobes (n) 82 (68-96)
 T1m 90 (79-100) 9 1
 T1sm 75 (59-91) 1 3
 T2 75 (59-91)  3  
 T3 100 (100-100) 1 5 2
 T4 50 (31-69) 2
3D-EUS (n) 96 (89-100)
 T1m 90 (79-100) 9
 T1sm 100 (100-100) 1 4
 T2 100 (100-100) 4
 T3 100 (100-100)  5
 T4 100 (100-100)  4
es. Of the 27 patients that underwent surgery, it was not 
possible to obtain this information in six (22.2%) cases as 
a transanal resection was performed. N staging by C-EUS, 
mp-EUS and 3D-EUS and pathological analysis were con-
cordant with respective kappa coefficients of 0.80, 0.59 and 
1. The sensitivity of C-EUS, mp-EUS and 3D-EUS for the 
identification of metastasized nodes was 77.8%, 55.6% and 
100%, respectively. The corresponding values for specific-
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ity and positive predictive values were 100% for the three 
techniques, whereas the negative predictive values were 
85.7%, 75% and 100% and global accuracy was 90.5%, 81% 
and 100%, respectively.
Simultaneous comparison of N staging accuracy using 
the three EUS techniques and N APS (n = 21) (Table 4)
There were no significant differences between the three 
techniques (c2 = 4.42; p = 0.11).
DISCUSSION
The continuous technological development has led to the 
application of new techniques associated with endoscopic 
ultrasonography (19). Good results were obtained in this 
study with mini-probes and three-dimensional endoscopic 
ultrasonography.
There was a significant agreement with regard to T stag-
ing between miniprobes, 3D and conventional EUS. These 
values range between 77 and 93% in previous reports 
(12,14,16,17). Our findings confirm the high accuracy of 
3D-EUS, which is higher than that of conventional EUS. 
However, stenosing rectal cancer cannot be assessed 
either by C-EUS or 3D-EUS in up to 21.6% of cases (20), the 
rate was 15% in our study. Interestingly, miniprobe-EUS 
allowed the identification of most lesions in their entirety. 
Miniprobes can in fact transpose stenosing RC (Fig. 1), over-
coming the rigid end and “large” diameter characteristics 
of C-EUS, which may inhibit RC staging (4,7). 
Both 3D-EUS and mp-EUS had a high accuracy (Fig. 2) for 
T1 staging, which is in agreement with previous reports 
(21,22). With regard to T2 staging, 3D was superior to 
mp-EUS, which tended to overstage tumors (12,16,17,22-
24). A very high accuracy for T3 staging was reported for 
3D or mp-EUS (12,16,17,23-26), whereas mp-EUS had the 
lowest accuracy in relation to the higher ultrasound fre-
quency for T4 staging, which is in line with current evidence 
(17,24-27). The use of 3D for T staging of rectal cancer had 
the best accuracy with mp and allowed the staging of ste-
nosing tumors, although with some limitations for large 
masses (e.g., T4 staging). 
Table 4. Accuracy and agreement for N staging using 
pathology as a reference for conventional EUS (C-EUS) 
(accuracy = 90%, kappa = 0.80), miniprobes (accuracy 
= 81%, kappa = 0.59) and 3D-EUS (accuracy = 100%, 
kappa=1). Total n = 21
Accuracy (%)
Pathology
N staging
N0 N+
C-EUS (n) 90 (77-100)
 N0 86 (71-100) 12
 N+ 100 (100-100) 2 7
Miniprobes (n) 81 (64-98)
 N0 100 (100-100) 12 4
 N+ 56 (38-77) 5
3D-EUS (n) 100 (100-100)
 N0 100 (100-100) 12
 N+ 100 (100-100) 9
Table 3. Accuracy and agreement for N staging 
using conventional EUS (C-EUS) as a reference for 
miniprobes (accuracy = 83%, kappa = 0.65) and 3D-EUS 
(accuracy = 85%, kappa = 0.70). Total n = 60
Accuracy (%)
C-EUS (n)
N staging
N0 N+
Miniprobes (n) 83 (69-97)
 N0 91 (80-100) 31 7
 N+ 73 (56-90) 3 19
3D-EUS (n) 85 (72-98)
 N0 79 (64-94) 27 2
 N+ 92 (82-100) 7 24
Fig. 1. Stenosing RC. A. Observation by colonoscopy with 
a miniprobe inserted in the lumen. B. Ultrasonographic 
image showing the invasion by perirectal fat.
Fig. 2. RC staging by 3D-EUS with invasion of the 
submucosa but without surpassing it, as confirmed by 
the surgical sample. 
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With regard to lymph node diagnosis with EUS, the results 
obtained with mp-EUS and 3D-EUS were also encourag-
ing since they were in significant concordance with C-EUS, 
with a global accuracy of 90.5%. The highest sensitivity 
was obtained with 3D-EUS (100%), as well as a very high 
negative predictive value (100%). This not only represents 
the high capacity of 3D-EUS to identify lymph nodes but 
also reinforces our option for not imposing a cut-off value 
for node diameter in order to classify it as metastasized. 
However, there is no consensus with regard to this matter 
(28,29). In fact, this trend to improved accuracy was also 
observed in other studies (12,17,30,31).
In conclusion, Mp-EUS and 3D-EUS are valid techniques 
compared to C-EUS for RC staging. We suggest that 
Mp-EUS may be an alternative to C-EUS due to the possi-
bility of staging a carcinoma during colonoscopy with inter-
esting T-staging results, and it can usually assess the entire 
tumor mass. This is an advantage for stenosing masses. 
More importantly, even though the results were not statis-
tically significant in the comparison of 3D-EUS with C-EUS, 
this technique may become the gold standard method in RC 
staging. This will ultimately improve the clinical decisions 
taken with regard to these patients, particularly for T2 vs T3 
staging, which is highly relevant in patient management.
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